台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

0610_下午場_1.6_周吟柔醫師

2024-12-18 • 觀看: 0 • 回應: 0 • embed
7. MRDapplication in cancer treatment from advanced to early stage_李宛珊 (2024.11.03)

2024-12-18 • 觀看: 0 • 回應: 0 • embed
6. Breakthrough in lung cancer treatment: peri-operative immunotherapy_夏德椿 (2024.11.03)

2024-12-18 • 觀看: 0 • 回應: 0 • embed
5. Revolutionizing breast cancer treatment: peri-operative immunotherapy_林季宏 (2024.11.03)

2024-12-18 • 觀看: 0 • 回應: 0 • embed
4. Immunotherapy novel combination and potential breakthrough therapy in HNSCC_Dr. Mei-Kim Ang (2024.11.03)

2024-12-18 • 觀看: 1 • 回應: 0 • embed
3. What can we expect in the future development of oncology pipelines beyondADC?_陳偉武 (2024.11.03)

2024-12-18 • 觀看: 1 • 回應: 0 • embed
2. How physicians collaboratewith industry for drug development?_吳尚儒 (2024.11.03)

2024-12-18 • 觀看: 1 • 回應: 0 • embed
1. Tsunami in oncology: development in ADC_Dr.Andrea Lauer (2024.11.03)

2024-12-18 • 觀看: 1 • 回應: 0 • embed
2. Role of Immunotherapy inPerioperative Approach of Muscle InvasiveUrothelial Cancer_蔡育傑 (2024.11.02)

2024-12-18 • 觀看: 5 • 回應: 0 • embed
1. A New Era of Front-lineMetastatic Urothelial Cancer_Prof Eiji Kikuchi (2024.11.02)

2024-12-18 • 觀看: 8 • 回應: 0 • embed
【🎬線上】Advanced Prostate Cancer Webinar 2024-11-28 (四) 19:00 ~ 20:30

2024-12-18 • 觀看: 15 • 回應: 0 • embed
(WUF-2) Vesicoureteral reflux—an argument for CHOPserveration_Aseem Shukla

2024-12-14 • 觀看: 8 • 回應: 0 • 連結

Prev
130
131
132
133
134
135
136
137
138
139
Next
/ 1134